| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/24/2003 | WO2003059924A1 Novel binding epitopes for helicobacter pylori and use thereof |
| 07/24/2003 | WO2003059921A1 Mmp inhibitors |
| 07/24/2003 | WO2003059899A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | WO2003059893A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | WO2003059891A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | WO2003059889A1 Process for producing fused imidazole compound, reformatsky reagent in stable form, and process for producing the same |
| 07/24/2003 | WO2003059884A1 Modulators of lxr |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059834A1 Glass-ceramic composite containing nanoparticles |
| 07/24/2003 | WO2003059404A2 Preparation for wound healing and prevention of bandage adhesion to the wound |
| 07/24/2003 | WO2003059368A1 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts |
| 07/24/2003 | WO2003059366A1 Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient |
| 07/24/2003 | WO2003059353A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | WO2003059326A1 Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties |
| 07/24/2003 | WO2003059314A1 Use of methyl glycine diacetic acid or the derivatives thereof as an exfoliant |
| 07/24/2003 | WO2003059297A2 Dermatological topical compositions and a process for the preparation thereof |
| 07/24/2003 | WO2003059296A2 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | WO2003059294A2 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | WO2003059293A2 17-hydroxy-4-aza-androstan-3-ones as androgen receptor modulators |
| 07/24/2003 | WO2003059283A2 Compounds for blocking androgen receptors |
| 07/24/2003 | WO2003059282A2 Human monoclonal antibodies against cd30 |
| 07/24/2003 | WO2003059276A2 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | WO2003059269A2 Acridone inhibitors of impdh enzyme |
| 07/24/2003 | WO2003059264A2 Methods for the induction of professional and cytokine-producing regulatory cells |
| 07/24/2003 | WO2003059244A2 Cosmetic composition containing an oil extracted for murumuru seeds |
| 07/24/2003 | WO2003045333A3 Treatment of hyperproliferative diseases using active vitamin d analogues |
| 07/24/2003 | WO2003043572A3 Methods and compositions related to irm compounds and toll-like receptor pathways |
| 07/24/2003 | WO2003032918A3 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 07/24/2003 | WO2003032910A3 Carbinols for the treatment of neuropathic dysfunction |
| 07/24/2003 | WO2003032909A3 Methods of treating skin with diphosphonate derivatives |
| 07/24/2003 | WO2003028713A3 3,4-methylenedioxy-substituted chalcones as therapeutic agents |
| 07/24/2003 | WO2003006645A3 Method and composition for inhibiting heparanase activity |
| 07/24/2003 | WO2002067988A3 Use of natural egfr inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor |
| 07/24/2003 | WO2002060942A3 Protein modification and maintenance molecules |
| 07/24/2003 | WO2002019982A3 Cosmetic composition and method for reducing or preventing wrinkling |
| 07/24/2003 | US20030140358 Transgenic mammal coding serine protease inhibitor which is expressed in mammary gland tissue and products for treating immunosuppression disorders and angioedema |
| 07/24/2003 | US20030139597 Novel Cyclic hydroxamic acid as metalloproteinase inhibitors |
| 07/24/2003 | US20030139590 Comprises nucleotide sequences coding orphan receptor 25 for detecting modulators of platelet activating factor (PAF) activity; antiinflammatory agents; gene/translation inhibition; drug screening |
| 07/24/2003 | US20030139453 Difluorobutyric acid metalloprotease inhibitors |
| 07/24/2003 | US20030139452 Pyrazole-derived kinase inhibitors and uses thereof |
| 07/24/2003 | US20030139439 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 07/24/2003 | US20030139435 N-heterocyclic inhibitors of TNF-alpha expression |
| 07/24/2003 | US20030139417 Cyclopropane CGRP antagonists, medicaments containing these compounds, and method for the production thereof |
| 07/24/2003 | US20030139413 Novel 1,3-dihydro-2h-indol-2-one derivatives, preparation method and pharmaceutical composition containing them |
| 07/24/2003 | US20030139410 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 07/24/2003 | US20030139407 Efficient synthesis of 5-heteroatom-containing -pyrazoles |
| 07/24/2003 | US20030139402 Antiinflammatory agents; Alzheimer's disease; cardiovascular disorders |
| 07/24/2003 | US20030139400 Controlling cell differentiation; antiinflammatory agents |
| 07/24/2003 | US20030139399 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
| 07/24/2003 | US20030139376 Lipoxin A4 analogs |
| 07/24/2003 | US20030139355 Medicine for orthopaedic surgical application and a treating method using thereof |
| 07/24/2003 | US20030139353 Using topoisomerase inhibitor; antiarthritic agents; respiratory system disorders; skin disorders |
| 07/24/2003 | US20030139350 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 07/24/2003 | US20030138772 Polymerase chain reactions to screen and isolate parvovirus DNA obtained from tissue and/or cells without coinfection by helper viruses; gene therapy |
| 07/24/2003 | US20030138507 Plant extracts with anti-radical type action |
| 07/24/2003 | US20030138503 Topical pharmaceutical formulations and methods of treatment |
| 07/24/2003 | US20030138502 Method for protecting human skin |
| 07/24/2003 | US20030138476 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 07/24/2003 | US20030138467 Methods for improving the aesthetic appearance of skin |
| 07/24/2003 | US20030138421 Human Antibodies specific for interleukin 15 (IL-15) |
| 07/24/2003 | US20030138394 Slimming agents with anticellulite action; saponins |
| 07/24/2003 | US20030138393 Aging resistance |
| 07/24/2003 | US20030138390 Aging resistance |
| 07/24/2003 | US20030138386 Niobium, vanadium, antimony, tantalum, strontium, calcium, magnesium, barium, molybdenum or silicon oxides; paints, plastics, coatings, pigments, dyes and sunscreens |
| 07/24/2003 | CA2700690A1 Process for producing reformatsky reagent in stable form |
| 07/24/2003 | CA2474239A1 Substituted pyridazinones as inhibitors of p38 |
| 07/24/2003 | CA2474141A1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 07/24/2003 | CA2473908A1 Compounds for blocking androgen receptors |
| 07/24/2003 | CA2473039A1 Novel anti-igf-ir antibodies and uses thereof |
| 07/24/2003 | CA2472746A1 Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| 07/24/2003 | CA2472204A1 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases |
| 07/24/2003 | CA2472168A1 Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor |
| 07/24/2003 | CA2471744A1 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs3 upregulation |
| 07/24/2003 | CA2471702A1 Human monoclonal antibodies against cd30 |
| 07/24/2003 | CA2471562A1 Tyrosyl derivatives and their use as p2x7 receptor modulators |
| 07/24/2003 | CA2471480A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 07/24/2003 | CA2470649A1 Mmp inhibitors |
| 07/24/2003 | CA2470430A1 Compositions comprising collagen and metalloprotease inhibitors |
| 07/24/2003 | CA2469800A1 Methods for the induction of professional and cytokine-producing regulatory cells |
| 07/24/2003 | CA2469435A1 Modulators of lxr |
| 07/23/2003 | EP1329511A1 Polypeptide having phospholipase a2 actiivty |
| 07/23/2003 | EP1329451A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 07/23/2003 | EP1329223A1 Expression potentiator for protein synthesis regulatory gene |
| 07/23/2003 | EP1328653A2 Highly expressible genes |
| 07/23/2003 | EP1328646A2 Regulation of human adenylate cyclase, type iv |
| 07/23/2003 | EP1328634A2 Genes expressed in the cell cycle |
| 07/23/2003 | EP1328624A2 B7-like molecules and uses thereof |
| 07/23/2003 | EP1328622A2 Protein c or activated protein c-like molecules |
| 07/23/2003 | EP1328620A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells |
| 07/23/2003 | EP1328552A1 Crosslinked amide derivatives of hyaluronic acid and manufacturing method thereof |
| 07/23/2003 | EP1328548A2 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 07/23/2003 | EP1328539A1 Vegf peptides and their use for inhibiting angiogenesis |
| 07/23/2003 | EP1328519A2 Orally active salts with tyrosine kinase activity |
| 07/23/2003 | EP1328516A1 Novel neurokinin antagonists, method for the production thereof and pharmaceutical compositions containing said compounds |
| 07/23/2003 | EP1328510A2 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/23/2003 | EP1328319A1 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases |
| 07/23/2003 | EP1328294A2 Combination use of acetylcholinesterase inhibitors and gaba-a inverse agonists for the treatment of cognitive disorders |
| 07/23/2003 | EP1328289A2 Oxidized proteins, their biological activity, and therapeutic and diagnostic measures, which are derived from the active mechanism, from the use of these proteins or from the inhibition thereof |
| 07/23/2003 | EP1328288A2 Protein mixtures for wound healing |
| 07/23/2003 | EP1328283A1 Skin external preparation containing pine pollen or pine pollen extract |